Old National Bancorp’s Novartis NVS Stock Holding History

Old National Bancorp’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.54M	Sell	9,844 -20	-0.2%	-$3K	0.03%	255
2026 Q1	$1.51M	Buy	9,864 +51	+0.5%	+$7.82K	0.03%	268
2025 Q4	$1.35M	Buy	9,813 +738	+8%	+$96.6K	0.02%	280
2025 Q3	$1.16M	Sell	9,075 -451	-5%	-$55K	0.02%	296
2025 Q2	$1.15M	Sell	9,526 -917	-9%	-$103K	0.02%	295
2025 Q1	$1.16M	Sell	10,443 -3,814	-27%	-$406K	0.03%	250
2024 Q4	$1.39M	Buy	14,257 +220	+2%	+$23.5K	0.03%	251
2024 Q3	$1.61M	Sell	14,037 -1,507	-10%	-$171K	0.04%	238
2024 Q2	$1.65M	Buy	15,544 +971	+7%	+$97.5K	0.04%	230
2024 Q1	$1.41M	Buy	14,573 +1,401	+11%	+$144K	0.03%	258
2023 Q4	$1.33M	Sell	13,172 -569	-4%	-$54.9K	0.04%	267
2023 Q3	$1.4M	Sell	13,741 -532	-4%	-$54K	0.04%	254
2023 Q2	$1.44M	Buy	14,273 +1,321	+10%	+$132K	0.04%	262
2023 Q1	$1.19M	Buy	12,952 +512	+4%	+$44.7K	0.04%	283
2022 Q4	$1.13M	Sell	12,440 -1,728	-12%	-$146K	0.04%	294
2022 Q3	$1.08M	Sell	14,168 -2,678	-16%	-$222K	0.04%	291
2022 Q2	$1.42M	Sell	16,846 -572	-3%	-$50.2K	0.05%	255
2022 Q1	$1.53M	Sell	17,418 -10	-0.1%	-$866	0.06%	209
2021 Q4	$1.52M	Buy	17,428 +885	+5%	+$73.5K	0.05%	214
2021 Q3	$1.35M	Sell	16,543 -4,487	-21%	-$404K	0.05%	230
2021 Q2	$1.92M	Buy	21,030 +6,706	+47%	+$597K	0.07%	200
2021 Q1	$1.22M	Sell	14,324 -1,024	-7%	-$91.9K	0.05%	237
2020 Q4	$1.45M	Sell	15,348 -1,806	-11%	-$158K	0.06%	224
2020 Q3	$1.49M	Buy	17,154 +4,228	+33%	+$366K	0.07%	206
2020 Q2	$1.13M	Buy	12,926 +3,543	+38%	+$306K	0.06%	219
2020 Q1	$774K	Buy	9,383 +2,002	+27%	+$179K	0.05%	229
2019 Q4	$699K	Sell	7,381 -260	-3%	-$23.3K	0.03%	284
2019 Q3	$664K	Sell	7,641 -2,609	-25%	-$234K	0.03%	290
2019 Q2	$936K	Sell	10,250 -6,642	-39%	-$562K	0.05%	250
2019 Q1	$1.46M	Sell	16,892 -1,615	-9%	-$130K	0.08%	202
2018 Q4	$1.42M	Buy	18,507 +3,612	+24%	+$281K	0.08%	192
2018 Q3	$1.15M	Sell	14,895 -1,536	-9%	-$114K	0.06%	232
2018 Q2	$1.11M	Buy	16,431 +4,405	+37%	+$304K	0.06%	230
2018 Q1	$871K	Sell	12,026 -1,404	-10%	-$107K	0.05%	258
2017 Q4	$1.01M	Sell	13,430 -1,408	-9%	-$106K	0.05%	246
2017 Q3	$1.14M	Sell	14,838 -167	-1%	-$12.6K	0.06%	221
2017 Q2	$1.12M	Sell	15,005 -7,473	-33%	-$530K	0.06%	221
2017 Q1	$1.5M	Buy	22,478 +353	+2%	+$23.5K	0.08%	194
2016 Q4	$1.44M	Sell	22,125 -1,712	-7%	-$111K	0.08%	197
2016 Q3	$1.69M	Sell	23,837 -1,068	-4%	-$77.8K	0.1%	168
2016 Q2	$1.84M	Sell	24,905 -1,152	-4%	-$79.6K	0.1%	147
2016 Q1	$1.69M	Sell	26,057 -1,072	-4%	-$72.9K	0.1%	158
2015 Q4	$2.09M	Sell	27,129 -2,412	-8%	-$192K	0.12%	131
2015 Q3	$2.43M	Buy	29,541 +307	+1%	+$27.3K	0.15%	125
2015 Q2	$2.58M	Sell	29,234 -8,181	-22%	-$751K	0.14%	123
2015 Q1	$3.31M	Buy	37,415 +8,573	+30%	+$760K	0.18%	111
2014 Q4	$2.4M	Sell	28,842 -1,855	-6%	-$154K	0.15%	107
2014 Q3	$2.59M	Buy	30,697 +4,398	+17%	+$356K	0.17%	104
2014 Q2	$2.13M	Buy	26,299 +10,579	+67%	+$832K	0.16%	95
2014 Q1	$1.2M	Sell	15,720 -607	-4%	-$44.2K	0.11%	115
2013 Q4	$1.18M	Sell	16,327 -1,704	-9%	-$118K	0.11%	87
2013 Q3	$1.24M	Buy	18,031 +212	+1%	+$14K	0.13%	75
2013 Q2	$1.13M	Buy	+17,819	New	+$1.16M	0.12%	78

Other funds holding NVS

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GGI

Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

MIM

Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Old National Bancorp's NVS Position: Q2 2026 in Review

Old National Bancorp reduced its Novartis (NVS) stake by 0.2% in Q2 2026, selling an estimated $3K and leaving 9,844 shares worth $1.54M. The position accounts for 0.03% of the portfolio, ranked #255.

Old National Bancorp first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.31M in Q1 2015. 509 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Old National Bancorp held 9,844 shares of Novartis worth $1.54M as of Q2 2026.
Old National Bancorp sold 20 Novartis shares in Q2 2026, an estimated $3K.
Novartis made up 0.03% of Old National Bancorp's portfolio in Q2 2026, its #255 holding.
Old National Bancorp first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
Old National Bancorp's Novartis position peaked at $3.31M in Q1 2015.
509 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.